Get Stix Inc.

Get Stix Inc. produces a range of devices including basic male condoms made from Hevea-latex, rapid in-vitro diagnostic (IVD) kits for detecting luteinizing hormone (LH) and human chorionic gonadotropin (hCG), unscented menstrual pads, vaginal pH screening kits designed for self-testing, and urine test strip color charts. These products span both consumer and clinical applications, with some devices intended for home use and others for professional healthcare settings.

Get Stix Inc. is based in the United States, which means its devices are subject to FDA regulations. The FDA classifies their products as either Class I or Class II, depending on the risk level and intended use. For example, condoms and menstrual pads typically fall under Class I due to their lower risk profile, while rapid IVD kits for detecting LH or hCG may be classified as Class II due to their role in diagnosing conditions like infertility or pregnancy.

Get Stix Inc.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. The UDI system ensures traceability and transparency in the medical device supply chain by assigning a unique product identifier to each device, which helps regulators, healthcare providers, and patients track specific products. This listing is particularly useful for verifying device details like manufacturer information, model names, and regulatory classifications.

The FDA classifies Get Stix Inc.’s devices as either Class I or Class II. Class I devices, like basic condoms and menstrual pads, generally pose minimal risk and may only require general controls like good manufacturing practices. Class II devices, such as rapid IVD kits for LH or hCG detection, involve moderate risk and may require additional controls like performance standards or post-market surveillance to ensure safety and effectiveness. This classification influences the regulatory requirements the company must meet, including labeling, testing, and reporting obligations.

Get Stix Inc.’s IVD products, such as rapid kits for detecting LH and hCG, are designed to diagnose medical conditions by analyzing human samples like urine. Unlike condoms or menstrual pads, which are primarily protective or absorptive, these IVD kits are classified under stricter regulatory oversight due to their role in clinical decision-making. They often require validation for accuracy, sensitivity, and specificity to ensure reliable results, which differentiates them from lower-risk devices and justifies their potential Class II classification.